Optimizing Outcomes in Patients With Inflammatory Bowel Diseases: The Critical Role of the GI Nurse

In this video module, Karen A. Hanson, APRN, CNP, and Joshua Korzenik, MD, discuss effective multidisciplinary approaches to caring for patients with IBD.
Karen A. Hanson, APRN, CNP
Joshua Korzenik, MD
Physicians: maximum of 0.75 AMA PRA Category 1 Credits
Registered Nurses: 0.6 Nursing contact hours
Released: April 5, 2017 Expiration: April 4, 2018
Multimedia Optimizing Outcomes in Patients With Inflammatory Bowel Diseases: The Critical Role of the GI Nurse
This program is divided into approximately 5-15-minute segments. After reviewing all segments, click the Claim Credit button to complete the CME posttest and evaluation.
Overview: Sustained Disease Control (4 mins)
Karen A. Hanson, APRN, CNP, and Joshua Korzenik, MD, introduce the multidisciplinary approach to caring for patients with IBD.
Launch Overview: Sustained Disease Control (4 mins)
Part 2: Assessment and Triage (9 mins)
Review strategies for effective baseline evaluation and longitudinal monitoring to improve treatment outcomes.
Launch Part 2: Assessment and Triage (9 mins)
Part 3: Patient Education (16 mins)
Explore psychosocial factors and how to reinforce and communicate the risks and benefits of different treatment options.
Launch Part 3: Patient Education (16 mins)
Part 4: Improving Adherence (6 mins)
Learn key steps to involving patients in their care to improve adherence.
Launch Part 4: Improving Adherence (6 mins)

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Appropriately assess and risk stratify patients with IBD in order to optimize screening and preventive care measures
  • Evaluate the risk and benefit profiles of available treatment options in order to appropriately monitor patients undergoing treatment for IBD
  • Apply the principles of shared decision making and strategies to promote adherence in the care of patients with IBD

Acknowledgements

Jointly provided by Postgraduate Institute for Medicine, Clinical Care Options, LLC, and the Crohn's & Colitis Foundation.
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Produced in collaboration with
Supported by an educational grant from
Takeda Pharmaceuticals USA, LLC

Information on this Educational Activity

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Faculty

Karen A. Hanson, APRN, CNP

Adult Nurse Practitioner
Division of Gastroenterology
Department of Medicine
Mayo Clinic
Rochester, Minnesota

Karen A. Hanson, APRN, CNP, has no real or apparent conflicts of interest to report.
Joshua Korzenik, MD

Director, BWH Crohn's and Colitis
Department of Gastroenterology
Brigham and Women's Hospital
Harvard Medical School
Boston, Massachusetts

Joshua Korzenik, MD, has disclosed that he has received intellectual property/patent rights from ColonaryConcepts, consulting fees from AbbVie and Janssen, and funds for research support from Pfizer and Takeda.

Staff

Megan K. Murphy, PhD

Scientific Director

Megan K. Murphy, PhD, has no real or apparent conflicts of interest to report.
Jenny Schulz, PhD

Director, Scientific Services

Jenny Schulz, PhD, has no real or apparent conflicts of interest to report.
Zachary Schwartz, MSc

Scientific Director

Zachary Schwartz, MSc, ELS, has no real or apparent conflicts of interest to report.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following Crohn's and Colitis Foundation staff, Orna G. Ehrlich, MPH, has no real or apparent conflicts of interest to report.

The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This activity is intended for gastroenterology nurses who are involved in the care of patients with inflammatory bowel diseases.

Goal

The goal of this activity is to improve the knowledge and competence of gastroenterology nurses in providing evidence-based care to patients with inflammatory bowel diseases.

Physician Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine, Crohn's & Colitis Foundation, and Clinical Care Options, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Credit Designation

This educational activity for 0.6 contact hour is provided by Postgraduate Institute for Medicine.

Accreditation Statement

Postgraduate Institute for Medicine is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.75 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from April 05, 2017, through April 04, 2018:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Related Content

Patient cases on diagnosis, including overlooked signs and symptoms, lab and genetic tests, and more

person default Herbert L. Bonkovsky, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: March 31, 2020 Expired: March 30, 2021

Uma Mahadeven, MD, and Marla Dubinsky, MD: expert commentary on preconception strategies to ensure safe, effective IBD control before and during pregnancy

Marla Dubinsky, MD Uma Mahadevan, MD Released: March 25, 2020

Interactive on-demand Webcast from CCO featuring expert discussion on managing patients at risk for recurrent hepatic encephalopathy

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?